Insider · CIK 0001627976
Brian D Paliotti
Files at NEU (NEWMARKET CORP). First filing -, latest -.
In brief
Brian D Paliotti files SEC Form 4 as president at NEU (NEWMARKET CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Brian D Paliotti has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | NEU NEWMARKET CORP | AGrant or award Common Stock | +535 | $0.00 | $0 | 3,410 | Feb 9, 2026 |
| Feb 5, 2026 | NEU NEWMARKET CORP | FTax withholding Common Stock | -171 | $714.88 | $122k | 3,239 | Feb 9, 2026 |
| Feb 22, 2024 | NEU NEWMARKET CORP | AGrant or award Common Stock | +437 | $0.00 | $0 | 2,658 | Feb 26, 2024 |
| Feb 22, 2024 | NEU NEWMARKET CORP | FTax withholding Common Stock | -132 | $619.19 | $82k | 2,526 | Feb 26, 2024 |
Questions about Brian D Paliotti
Answered from the filings on this page, as of the latest one.
Is Brian D Paliotti buying or selling?
Brian D Paliotti has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Brian D Paliotti's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian D Paliotti has 0.
Where does Brian D Paliotti file Form 4?
Brian D Paliotti has filed Form 4 at NEU (NEWMARKET CORP) as President Afton Chemical Corp. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.